Genomic technologies: development and clinical application
Guest editor: Stephen Kingsmore
Genome Medicine is pleased to announce a special issue on Genomic technologies: development and clinical application for publication in Spring 2017.
In this special issue we will capture the recent advances in a broad range of genomic technologies with potential to aid in understanding, preventing, diagnosing and treating disease. These can be in the stages of development, transition to the clinic or under clinical implementation.
We welcome the submission of Research, Method and Software manuscripts of broad interest describing advances in the development and application of technologies for translational purposes in topics including, but not limited to:
- Innovations in DNA and RNA sequencing (e.g. rapid, long read and portable sequencing)
- Improvements in genome assembly, phasing, imputation, and structural variant detection
- Genome and epigenome engineering, using CRISPR and other systems
- Single-cell omics
- Multi ‘omics
- Single-molecule analysis
- Nucleic acid therapies (e.g. gene and RNAi)
- Cellular therapies (e.g. stem cells and CAR T cells)
- Microbiome analysis
- Technologies for assessing 3D genome architecture
- Data analysis, sharing and storage
- Emerging technologies (e.g. biosensor and synthetic genomes)
Due to popular demand the deadline for submissions has now been extended to 20 March 2017. To submit your manuscript, please use Genome Medicine’s online submission system. Please indicate in your covering letter that you would like the article to be considered for the ‘Genomic technologies: development and clinical application’ special issue. If you would like to enquire about the suitability of a study for consideration, please email firstname.lastname@example.org.